Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • PacBio Aims for Sub-$300 Genomes with Reusable SMRT Cells

    Bio-IT World | Pacific Biosciences announced a chemistry upgrade and SMRT cell reuse capability last month at the American Society of Human Genetics (ASHG) meeting. CEO Christian Henry said the moves targeted dramatic price reductions for customers and to compete with short-read sequencing.

    Nov 4, 2025
  • NVIDIA Unveils Quantum-AI Integration and Record-Breaking Blackwell Architecture at GTC 2025

    Bio-IT World | NVIDIA CEO Jensen Huang used NVIDIA’s GTC 2025 keynote to share his vision for the convergence of quantum computing and artificial intelligence, while revealing staggering demand for the company’s next-generation Grace Blackwell architecture that signals a fundamental shift in how the world computes.

    Oct 30, 2025
  • SandboxAQ Releases New AI Model, Illumina Launches New Business, Thermo Fisher’s New Analyzer

    Bio-IT World | SandboxAQ releases AQCat25-EV2, a new quantitative AI model trained on the AQCat25 dataset; Illumina launches BioInsight, a new business within Illumina developed to meet industry demand for deeper biologic insights; Thermo Fisher Scientific introduces the Applied Biosystems SwiftArrayStudio Microarray Analyzer; and more.

    Oct 29, 2025
  • Follow the Money: Potential Best-in-Category Weight Loss Drug, Tubulis’ ADC Advancement, Trojan Horse Treatment for Cancer

    Bio-IT World | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Tubulis develops antibody-drug conjugate for ovarian cancer and lung adenocarcinomas; Trogenix advances their pipeline of potentially curative cancer therapies across multiple aggressive solid tumors into the clinic; and more.

    Oct 28, 2025
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27 (current)
  • 28
  • 29
  • 30
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy